SPIRIT 2013 statement: defining standard protocol items for clinical trials.

dc.contributor.author

Chan, An-Wen

dc.contributor.author

Tetzlaff, Jennifer M

dc.contributor.author

Altman, Douglas G

dc.contributor.author

Laupacis, Andreas

dc.contributor.author

Gøtzsche, Peter C

dc.contributor.author

Krleža-Jerić, Karmela

dc.contributor.author

Hróbjartsson, Asbjørn

dc.contributor.author

Mann, Howard

dc.contributor.author

Dickersin, Kay

dc.contributor.author

Berlin, Jesse A

dc.contributor.author

Doré, Caroline J

dc.contributor.author

Parulekar, Wendy R

dc.contributor.author

Summerskill, William SM

dc.contributor.author

Groves, Trish

dc.contributor.author

Schulz, Kenneth F

dc.contributor.author

Sox, Harold C

dc.contributor.author

Rockhold, Frank W

dc.contributor.author

Rennie, Drummond

dc.contributor.author

Moher, David

dc.coverage.spatial

United States

dc.date.accessioned

2015-12-03T17:51:20Z

dc.date.issued

2013-02-05

dc.description.abstract

The protocol of a clinical trial serves as the foundation for study planning, conduct, reporting, and appraisal. However, trial protocols and existing protocol guidelines vary greatly in content and quality. This article describes the systematic development and scope of SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) 2013, a guideline for the minimum content of a clinical trial protocol.The 33-item SPIRIT checklist applies to protocols for all clinical trials and focuses on content rather than format. The checklist recommends a full description of what is planned; it does not prescribe how to design or conduct a trial. By providing guidance for key content, the SPIRIT recommendations aim to facilitate the drafting of high-quality protocols. Adherence to SPIRIT would also enhance the transparency and completeness of trial protocols for the benefit of investigators, trial participants, patients, sponsors, funders, research ethics committees or institutional review boards, peer reviewers, journals, trial registries, policymakers, regulators, and other key stakeholders.

dc.identifier

https://www.ncbi.nlm.nih.gov/pubmed/23295957

dc.identifier

1556168

dc.identifier.eissn

1539-3704

dc.identifier.uri

https://hdl.handle.net/10161/11031

dc.language

eng

dc.publisher

American College of Physicians

dc.relation.ispartof

Ann Intern Med

dc.relation.isversionof

10.7326/0003-4819-158-3-201302050-00583

dc.subject

Checklist

dc.subject

Clinical Protocols

dc.subject

Clinical Trials as Topic

dc.subject

Humans

dc.title

SPIRIT 2013 statement: defining standard protocol items for clinical trials.

dc.type

Journal article

duke.contributor.orcid

Rockhold, Frank W|0000-0003-3732-4765

pubs.author-url

https://www.ncbi.nlm.nih.gov/pubmed/23295957

pubs.begin-page

200

pubs.end-page

207

pubs.issue

3

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Biostatistics & Bioinformatics

pubs.organisational-group

Duke

pubs.organisational-group

Duke Clinical Research Institute

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

School of Medicine

pubs.publication-status

Published

pubs.volume

158

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Ann Intern Med.pdf
Size:
124.35 KB
Format:
Adobe Portable Document Format